Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Anterior Nares Nasal Samples For Point-of-Care (POC) Use

NCT05787444 is registered in ClinicalTrials.gov with LumiraDx UK Limited as lead sponsor.

NCT NCT05787444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05787444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Anterior Nares Nasal Samples For Point-of-Care (POC) Use
Lead sponsor
LumiraDx UK Limited
Phase
Observational
Overall status
Completed
Start date
May 4, 2023
Completion date
April 2, 2024
Enrollment
1,081 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic covid-19, influenza a, influenza b, sars-cov-2